Analysts expect Stoke Therapeutics, Inc. to report revenue of 8.71 M for Q3 26, against a range of 8.43 M to 8.98 M. The most recent reported quarter, Q2 26, came in at 9.32 M, a 79.6% beat against the 5.19 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.89 M | 22.61 M | 158.57 M | 13.82 M | 10.63 M | 1.40 M | 6.23 M | 9.32 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 4.35 M | 4.31 M | 29.12 M | 9.40 M | 6.03 M | 6.30 M | 6.46 M | 5.56 M | 8.98 M | 8.63 M | 7.66 M | 7.10 M | 9.32 M | 9.01 M | 39.22 M | 22.75 M | ||||||||||
| Low Estimate | 3.61 M | 3.72 M | 26.42 M | 7.98 M | 5.47 M | 5.65 M | 5.96 M | 4.82 M | 8.43 M | 7.41 M | 6.81 M | 5.99 M | 8.23 M | 8.22 M | 36.22 M | 19.73 M | ||||||||||
| Consensus Estimate | 3.98 M | 4.01 M | 27.77 M | 8.69 M | 5.75 M | 5.97 M | 6.21 M | 5.19 M | 8.71 M | 8.02 M | 7.24 M | 6.55 M | 8.77 M | 8.61 M | 37.72 M | 21.24 M |
Analysts expect Stoke Therapeutics, Inc. to report earnings per share of -0.87 for Q3 26, against a range of -0.90 to -0.84. The most recent reported quarter, Q2 26, came in at -0.93, a 10.7% miss against the -0.84 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.47 | -0.18 | 1.90 | -0.40 | -0.65 | -0.96 | -0.79 | -0.93 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.46 | -0.48 | 0.12 | -0.47 | -0.53 | -0.70 | -0.79 | -0.77 | -0.84 | -0.88 | -0.91 | -0.94 | -0.91 | -0.94 | -0.38 | -0.63 | ||||||||||
| Low Estimate | -0.50 | -0.56 | 0.10 | -0.51 | -0.63 | -0.74 | -0.91 | -0.91 | -0.90 | -0.94 | -1.09 | -1.08 | -1.09 | -1.10 | -0.44 | -0.77 | ||||||||||
| Consensus Estimate | -0.48 | -0.52 | 0.11 | -0.49 | -0.58 | -0.72 | -0.85 | -0.84 | -0.87 | -0.91 | -1.00 | -1.01 | -1.00 | -1.02 | -0.41 | -0.70 |
Pull Wall Street consensus for Stoke Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=STOK&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "STOK", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=STOK&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();